Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

• Main Authors: Peng Cao (Author), Qilin Zhang (Author), Sanlan Wu (Author), Mitchell A. Sullivan (Author), Yifei Huang (Author), Weijing Gong (Author), Yongning Lv (Author), Xuejia Zhai (Author), Yu Zhang (Author)
• Format: Book
• Published: Compuscript Ltd, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a preparation widely used in chemotherapy for cancers. However, only some patients benefit from this treatment. Therefore, identifying which patients will respond to nab-paclitaxel therapy is crucial. Methods: A cohort of 32 patie...